IMAC (NASDAQ:BACK – Get Free Report) is anticipated to release its resultson Tuesday, November 17th. Analysts expect IMAC to post earnings of ($4.10) per share and revenue of $3.70 million for the quarter.
IMAC Stock Performance
NASDAQ:BACK opened at $0.00 on Tuesday. IMAC has a 12-month low of $0.00 and a 12-month high of $0.21.
IMAC Company Profile
IMAC Holdings, Inc (NASDAQ: BACK) is a healthcare company that historically operated outpatient clinics under the IMAC Regeneration Centers brand. The company focused on regenerative medicine, orthopedic care and sports medicine, with an emphasis on non-surgical treatment options for musculoskeletal conditions and injuries.
Its services included consultations, physical therapy, chiropractic care and regenerative treatment programs intended to support patients dealing with joint, spine and soft-tissue conditions.
Further Reading
- Five stocks we like better than IMAC
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for IMAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAC and related companies with MarketBeat.com's FREE daily email newsletter.
